Logo image of PHYS

SPROTT PHYSICAL GOLD TRUST (PHYS) Stock Overview

USA - NYSEARCA:PHYS - CA85207H1047

28.915 USD
+0.2 (+0.68%)
Last: 9/23/2025, 3:26:09 PM
Fundamental Rating

3

Overall PHYS gets a fundamental rating of 3 out of 10. We evaluated PHYS against 0 industry peers in the Unkown industry. The financial health of PHYS is average, but there are quite some concerns on its profitability. While showing a medium growth rate, PHYS is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year PHYS was profitable.
PHYS had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: PHYS reported negative net income in multiple years.
PHYS had a negative operating cash flow in each of the past 5 years.
PHYS Yearly Net Income VS EBIT VS OCF VS FCFPHYS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

1.2 Ratios

Industry RankSector Rank
ROA 26.73%
ROE 26.73%
ROIC 21.12%
ROA(3y)9.9%
ROA(5y)8.21%
ROE(3y)9.91%
ROE(5y)8.21%
ROIC(3y)N/A
ROIC(5y)N/A
PHYS Yearly ROA, ROE, ROICPHYS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

PHYS's Profit Margin has been stable in the last couple of years.
In the last couple of years the Operating Margin of PHYS has remained more or less at the same level.
In the last couple of years the Gross Margin of PHYS has remained more or less at the same level.
Industry RankSector Rank
OM 98.82%
PM (TTM) 98.82%
GM 99.95%
OM growth 3Y-4.06%
OM growth 5Y0.25%
PM growth 3Y-4.06%
PM growth 5Y0.25%
GM growth 3Y-0.27%
GM growth 5Y0.09%
PHYS Yearly Profit, Operating, Gross MarginsPHYS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80 100

More info and screens

6

2. Health

2.1 Basic Checks

PHYS has more shares outstanding than it did 1 year ago.
The number of shares outstanding for PHYS has been increased compared to 5 years ago.
PHYS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
PHYS Yearly Shares OutstandingPHYS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
PHYS Yearly Total Debt VS Total AssetsPHYS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

PHYS has an Altman-Z score of 26395.21. This indicates that PHYS is financially healthy and has little risk of bankruptcy at the moment.
There is no outstanding debt for PHYS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 26395.21
ROIC/WACCN/A
WACCN/A
PHYS Yearly LT Debt VS Equity VS FCFPHYS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B

2.3 Liquidity

PHYS has a Current Ratio of 39482.47. This indicates that PHYS is financially healthy and has no problem in meeting its short term obligations.
A Quick Ratio of 39482.47 indicates that PHYS has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 39482.47
Quick Ratio 39482.47
PHYS Yearly Current Assets VS Current LiabilitesPHYS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 141.03% over the past year.
Measured over the past years, PHYS shows a quite strong growth in Earnings Per Share. The EPS has been growing by 18.47% on average per year.
PHYS shows a strong growth in Revenue. In the last year, the Revenue has grown by 155.11%.
Measured over the past years, PHYS shows a very strong growth in Revenue. The Revenue has been growing by 36.50% on average per year.
EPS 1Y (TTM)141.03%
EPS 3YN/A
EPS 5Y18.47%
EPS Q2Q%83.56%
Revenue 1Y (TTM)155.11%
Revenue growth 3YN/A
Revenue growth 5Y36.5%
Sales Q2Q%112.03%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PHYS Yearly Revenue VS EstimatesPHYS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 3.85, which indicates a rather cheap valuation of PHYS.
PHYS is valuated cheaply when we compare the Price/Earnings ratio to 27.41, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 3.85
Fwd PE N/A
PHYS Price Earnings VS Forward Price EarningsPHYS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PHYS Per share dataPHYS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20 25

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.21
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

PHYS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SPROTT PHYSICAL GOLD TRUST

NYSEARCA:PHYS (9/23/2025, 3:26:09 PM)

28.915

+0.2 (+0.68%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)11-13 2025-11-13
Inst OwnersN/A
Inst Owner Change16.74%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap13.42B
Analysts0
Price TargetN/A
Short Float %0.2%
Short Ratio0.39
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 3.85
Fwd PE N/A
P/S 4.15
P/FCF N/A
P/OCF N/A
P/B 1.12
P/tB 1.12
EV/EBITDA N/A
EPS(TTM)7.52
EY26.01%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.08
FCFYN/A
OCF(TTM)-0.08
OCFYN/A
SpS6.97
BVpS25.78
TBVpS25.78
PEG (NY)N/A
PEG (5Y)0.21
Profitability
Industry RankSector Rank
ROA 26.73%
ROE 26.73%
ROCE 26.73%
ROIC 21.12%
ROICexc N/A
ROICexgc N/A
OM 98.82%
PM (TTM) 98.82%
GM 99.95%
FCFM N/A
ROA(3y)9.9%
ROA(5y)8.21%
ROE(3y)9.91%
ROE(5y)8.21%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-4.06%
OM growth 5Y0.25%
PM growth 3Y-4.06%
PM growth 5Y0.25%
GM growth 3Y-0.27%
GM growth 5Y0.09%
F-ScoreN/A
Asset Turnover0.27
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 39482.47
Quick Ratio 39482.47
Altman-Z 26395.21
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)141.03%
EPS 3YN/A
EPS 5Y18.47%
EPS Q2Q%83.56%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)155.11%
Revenue growth 3YN/A
Revenue growth 5Y36.5%
Sales Q2Q%112.03%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y157.53%
EBIT growth 3YN/A
EBIT growth 5Y36.84%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-51.84%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-51.84%
OCF growth 3YN/A
OCF growth 5YN/A